Hyprevention Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $16.1M

  • Investors
  • 8

Hyprevention General Information

Description

Operator of a medical company intended to develop implantable medical devices to address unmet clinical needs. The company's product is an implantable medical device indicated for internal fixation of the proximal femur of patients at risk of osteoporotic fracture and for impeding pathological fracture, enabling clinicians to treat osteoporotic, cancer-related conditions and improving patient outcomes.

Contact Information

Website
www.hypreventionusa.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1411 Broadway
  • New York, NY 10018
  • United States
+1 (772)
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Surgical Devices
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1411 Broadway
  • New York, NY 10018
  • United States
+1 (772)

Hyprevention Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hyprevention Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 01-May-2024 $16.1M Completed Generating Revenue
12. Later Stage VC 02-Mar-2023 Completed Generating Revenue
11. Later Stage VC 05-Apr-2022 Completed Generating Revenue
10. Seed Round 22-Jan-2018 Completed Generating Revenue
9. Seed Round 22-Jan-2018 Completed Generating Revenue
8. Seed Round 15-Dec-2015 Completed Generating Revenue
7. Seed Round 07-Oct-2014 Completed Startup
6. Angel (individual) 23-Apr-2013 Completed Startup
5. Angel (individual) 08-Oct-2012 $194K $338K Completed Startup
4. Angel (individual) 25-Aug-2011 $143K $143K Completed Startup
To view Hyprevention’s complete valuation and funding history, request access »

Hyprevention Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 37,500 $1.070679 $4.28 $4.28 1x $4.28 3.79%
Ordinary 50,000 $1.070679 $2.14 $2.14 1x $2.14 5.06%
To view Hyprevention’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Hyprevention Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a medical company intended to develop implantable medical devices to address unmet clinical needs. The compa
Medical Supplies
New York, NY
10 As of 2024

Portage, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hyprevention Competitors (1)

One of Hyprevention’s competitors is Stryker, a Formerly VC-backed company based in Portage, MI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Stryker Formerly VC-backed Portage, MI
You’re viewing 1 of 1 competitors. Get the full list »

Hyprevention Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Hyprevention Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015342167-A1 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014
AU-2015342167-B2 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014
CA-2963703-A1 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014
CA-2963703-C Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014
EP-3017780-A1 Implant for stabilizing fractured or non-fractured bones Inactive 04-Nov-2014 A61B17/725
To view Hyprevention’s complete patent history, request access »

Hyprevention Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hyprevention Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Caisse d'Epargne Corporation Minority
Yellowstone Holding Venture Capital Minority
Be Angels Angel Group Minority
Expanso Capital Corporate Venture Capital Minority
Sequoia Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Hyprevention FAQs

  • When was Hyprevention founded?

    Hyprevention was founded in 2010.

  • Where is Hyprevention headquartered?

    Hyprevention is headquartered in New York, NY.

  • What is the size of Hyprevention?

    Hyprevention has 10 total employees.

  • What industry is Hyprevention in?

    Hyprevention’s primary industry is Medical Supplies.

  • Is Hyprevention a private or public company?

    Hyprevention is a Private company.

  • What is Hyprevention’s current revenue?

    The current revenue for Hyprevention is .

  • How much funding has Hyprevention raised over time?

    Hyprevention has raised $26.9M.

  • Who are Hyprevention’s investors?

    Caisse d'Epargne, Yellowstone Holding, Be Angels, Expanso Capital, and Sequoia Capital are 5 of 8 investors who have invested in Hyprevention.

  • Who are Hyprevention’s competitors?

    Stryker is a competitor of Hyprevention.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »